Clearmind Medicine (CMND) recently announced that it signed a non-binding term sheet with Dr. Glitter Pty Ltd, a health ...

Clearmind Medicine (CMND) recently signed a non-binding term sheet with Dr. Glitter Pty Ltd, a health technology company that has ...

DALLAS, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Berry Corporation (bry) (NASDAQ: BRY) ("Berry” or the "Company”) announced the closing of a comprehensive refinancing of its existing indebtedness on December ...

Company recently signed a non-binding term sheet with Dr Glitter Pty Ltd for mutual development in ActivCrystal™ Format Vancouver, Canada, Dec. 26, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CMND), (FSE: CWY0 ...

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on discovery and development ...

On Tuesday, Clearmind Medicine Inc (CMND) stock saw a modest uptick, ending the day at $1.72 which represents a slight increase of $0.50 or 40.98% from the prior close of $1.22. The stock opened at $2 ...

Nov. 6, 2024 — Children whose mothers took extra vitamin D during pregnancy continue to have stronger bones at age seven, according to ... Two Key Genes Identified Linking Rheumatoid Arthritis ...

Clearmind Medicine's stock rose 63.9% after receiving IRB approval for its Phase I/IIa trial of CMND-100, a drug for alcohol ...

Shares of Clearmind Medicine more than doubled after the Institutional Review Board approved a clinical trial of its flagship compound as a treatment for alcohol use disorder. The stock was changing ...

US stock futures are treading water in Tuesday's premarket session ahead of a shortened trading day before the markets close for Christmas on Wednesday. The Dow Jones Industrial Average futures were ...

Clearmind Medicine (CMND) announced it has received Institutional Review Board approval for its Phase I/IIa clinical trial of CMND-100, ...

A drug that combines an atypical antipsychotic and an SSRI is under FDA review, and if approved will be the first ...